A Phase 3 Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of IV to Oral Omadacycline to Moxifloxacin for the Treatment of Adult Subjects with CABP (The OPTIC Study)

Open Forum Infectious Diseases ◽

10.1093/ofid/ofx163.1413 ◽

2017 ◽

Vol 4 (suppl_1) ◽

pp. S543-S544 ◽

Author(s):

Roman Stets ◽

Monica Popescu ◽

Joven Gonong ◽

Ismail Mitha ◽

William Nseir ◽

...

Keyword(s):

Phase 3 ◽

Double Blind ◽

Safety And Efficacy ◽

Multi Center Study ◽

Download Full-text

Follow-up results of a randomized, double-blind, phase III, multi-center study to evaluate the safety and efficacy of BF-200 ALA versus placebo in field-directed treatment of mild to moderate AK with photodynamic therapy when using narrowband red light

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.49 ◽

2019 ◽

Vol 3 ◽

pp. S49

Author(s):

U Reinhold ◽

T Dirschka ◽

R Ostendorf ◽

R Aschoff ◽

C Berking ◽

...

Keyword(s):

Photodynamic Therapy ◽

Red Light ◽

Phase Iii ◽

Double Blind ◽

Safety And Efficacy ◽

Multi Center Study ◽

Abstract not available.

Download Full-text

ENGAGE — A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in adults with Gaucher disease type 1: Results after 18months

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2014.12.179 ◽

2015 ◽

Vol 114 (2) ◽

pp. S81-S82 ◽

Author(s):

Pramod Mistry ◽

Dominick J. Amato ◽

Majed Dasouki ◽

Seymour Packman ◽

Gregory M. Pastores ◽

...

Keyword(s):

Gaucher Disease ◽

Disease Type ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Gaucher Disease Type 1 ◽

Multi Center Study ◽

Download Full-text

A randomized, double-blind, vehicle-controlled, multi-center study to evaluate the safety and efficacy of topically applied AN0128 cream, 1% for the treatment of mild to moderate atopic dermatitis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2006.10.348 ◽

2007 ◽

Vol 56 (2) ◽

pp. AB72

Keyword(s):

Atopic Dermatitis ◽

Double Blind ◽

Safety And Efficacy ◽

Multi Center Study ◽

Download Full-text

Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study To Evaluate The Safety And Efficacy Of Ciprofloxacin Dry Powder For Inhalation (Ciprofloxacin DPI) Compared With Placebo In Patients With Non-Cystic Fibrosis Bronchiectasis

10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a6407 ◽

2011 ◽

Author(s):

Robert Wilson ◽

Tobias Welte ◽

Eva Polverino ◽

Anthony De Soyza ◽

Hugh Greville ◽

...

Keyword(s):

Cystic Fibrosis ◽

Double Blind ◽

Safety And Efficacy ◽

Multi Center Study ◽

Download Full-text

A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9months of treatment

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2012.11.171 ◽

2013 ◽

Vol 108 (2) ◽

pp. S66-S67 ◽

Author(s):

Pramod Mistry ◽

Elena Lukina ◽

Marie-Françoise Ben Dridi ◽

Dominick Amato ◽

Hagit Baris ◽

...

Keyword(s):

Gaucher Disease ◽

Disease Type ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Gaucher Disease Type 1 ◽

Multi Center Study ◽

Download Full-text

Faculty Opinions recommendation of Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1141888.598992 ◽

2009 ◽

Author(s):

Claudia Sommer

Keyword(s):

Nerve Injury ◽

Double Blind ◽

Double Blind Placebo ◽

Multi Center Study ◽

Download Full-text

Spine Treatment Appraisal Report (STAR): Does Riluzole Improve Outcomes in Patients Undergoing Decompression Surgery for Degenerative Cervical Myelopathy?

Global Spine Journal ◽

10.1177/2192568221997401 ◽

2021 ◽

pp. 219256822199740

Author(s):

Joseph R. Dettori

Keyword(s):

Cervical Myelopathy ◽

Decompressive Surgery ◽

Decompression Surgery ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Degenerative Cervical Myelopathy

Fehlings MG, Badhiwala JH, Ahn H, et al. Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. Lancet Neurol. 2020.

Download Full-text

Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging

Journal of Nuclear Cardiology ◽

10.1007/s12350-021-02527-8 ◽

2021 ◽

Author(s):

Jamieson M. Bourque ◽

Christopher A. Hanson ◽

Denis Agostini ◽

Timothy M. Bateman ◽

Jeroen J. Bax ◽

...

Keyword(s):

Coronary Artery Disease ◽

Suspected Coronary Artery Disease ◽

Emission Tomography ◽

Second Phase ◽

Phase 3 ◽

Positron Emission ◽

Artery Disease ◽

Multi Center Study ◽

Download Full-text

Comparison of two corticosteroid regimens in combination with cellcept and cyclosporine a for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study

Transplantation Proceedings ◽

10.1016/s0041-1345(98)01522-x ◽

1999 ◽

Vol 31 (1-2) ◽

pp. 249-250 ◽

Author(s):

Y Lebranchu

Keyword(s):

Cyclosporine A ◽

Allograft Rejection ◽

Acute Allograft Rejection ◽

Double Blind ◽

Multi Center Study ◽

Download Full-text

Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet Neurology ◽

10.1016/s1474-4422(20)30407-5 ◽

2020 ◽

Author(s):

Michael G Fehlings ◽

Jetan H Badhiwala ◽

Henry Ahn ◽

H Francis Farhadi ◽

Christopher I Shaffrey ◽

...

Keyword(s):

Cervical Myelopathy ◽

Decompressive Surgery ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Degenerative Cervical Myelopathy

Download Full-text